These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 21668402

  • 1. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
    Noh RM, Graveling AJ, Frier BM.
    Expert Opin Pharmacother; 2011 Oct; 12(14):2161-75. PubMed ID: 21668402
    [Abstract] [Full Text] [Related]

  • 2. Increasing awareness of hypoglycaemia in patients with type 2 diabetes treated with oral agents.
    Barnett AH, Brice R, Hanif W, James J, Langerman H.
    Curr Med Res Opin; 2013 Nov; 29(11):1503-13. PubMed ID: 23952328
    [Abstract] [Full Text] [Related]

  • 3. [Hypoglycemia--a dreaded complication of diabetes].
    Bjørgaas M.
    Tidsskr Nor Laegeforen; 2000 Aug 30; 120(20):2441-4. PubMed ID: 11475234
    [Abstract] [Full Text] [Related]

  • 4. Impact of therapeutic advances on hypoglycaemia in type 2 diabetes.
    Boyle PJ, Zrebiec J.
    Diabetes Metab Res Rev; 2008 Aug 30; 24(4):257-85. PubMed ID: 18232062
    [Abstract] [Full Text] [Related]

  • 5. Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine.
    Janka HU.
    Diabetes Obes Metab; 2008 Jul 30; 10 Suppl 2():35-41. PubMed ID: 18577155
    [Abstract] [Full Text] [Related]

  • 6. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP, Schimke E.
    Med Klin (Munich); 1995 Oct 15; 90(10):557-61. PubMed ID: 7500918
    [Abstract] [Full Text] [Related]

  • 7. Role of vildagliptin in managing type 2 diabetes mellitus in the elderly.
    Halimi S, Raccah D, Schweizer A, Dejager S.
    Curr Med Res Opin; 2010 Jul 15; 26(7):1647-56. PubMed ID: 20441397
    [Abstract] [Full Text] [Related]

  • 8. Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes.
    Holstein A, Egberts EH.
    Exp Clin Endocrinol Diabetes; 2003 Oct 15; 111(7):405-14. PubMed ID: 14614647
    [Abstract] [Full Text] [Related]

  • 9. Hypoglycaemic valleys: an under-recognised problem in type 2 diabetes?
    Frier BM.
    Int J Clin Pract Suppl; 2002 Jul 15; (129):12-9. PubMed ID: 12166599
    [Abstract] [Full Text] [Related]

  • 10. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes.
    de Galan BE, Schouwenberg BJ, Tack CJ, Smits P.
    Neth J Med; 2006 Sep 15; 64(8):269-79. PubMed ID: 16990690
    [Abstract] [Full Text] [Related]

  • 11. Drug-induced hypoglycaemia in type 2 diabetes.
    Inkster B, Zammitt NN, Frier BM.
    Expert Opin Drug Saf; 2012 Jul 15; 11(4):597-614. PubMed ID: 22690846
    [Abstract] [Full Text] [Related]

  • 12. Basal insulins: Pharmacological properties and patient perspectives.
    Abrahamson MJ.
    Prim Care Diabetes; 2010 Apr 15; 4 Suppl 1():S19-23. PubMed ID: 20394887
    [Abstract] [Full Text] [Related]

  • 13. Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes.
    Barnett AH, Cradock S, Fisher M, Hall G, Hughes E, Middleton A.
    Int J Clin Pract; 2010 Jul 15; 64(8):1121-9. PubMed ID: 20236369
    [Abstract] [Full Text] [Related]

  • 14. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.
    Bruderer SG, Bodmer M, Jick SS, Bader G, Schlienger RG, Meier CR.
    Diabetes Obes Metab; 2014 Sep 15; 16(9):801-11. PubMed ID: 24612200
    [Abstract] [Full Text] [Related]

  • 15. The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review.
    Barendse S, Singh H, Frier BM, Speight J.
    Diabet Med; 2012 Mar 15; 29(3):293-302. PubMed ID: 21838763
    [Abstract] [Full Text] [Related]

  • 16. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
    Thomas RM, Aldibbiat A, Griffin W, Cox MA, Leech NJ, Shaw JA.
    Diabet Med; 2007 Jul 15; 24(7):778-83. PubMed ID: 17535290
    [Abstract] [Full Text] [Related]

  • 17. Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy.
    Barnett AH.
    Curr Med Res Opin; 2010 Jun 15; 26(6):1333-42. PubMed ID: 20370379
    [Abstract] [Full Text] [Related]

  • 18. Severe hypoglycaemia in type 1 diabetes: impact of the renin-angiotensin system and other risk factors.
    Pedersen-Bjergaard U.
    Dan Med Bull; 2009 Nov 15; 56(4):193-207. PubMed ID: 19939337
    [Abstract] [Full Text] [Related]

  • 19. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K, Janssen MM, Keulen ET, Jacobs MA, Popp-Snijders C, Snoek FJ, Heine RJ.
    Diabetologia; 1998 Mar 15; 41(3):322-9. PubMed ID: 9541173
    [Abstract] [Full Text] [Related]

  • 20. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
    Cariou B, Fontaine P, Eschwege E, Lièvre M, Gouet D, Huet D, Madani S, Lavigne S, Charbonnel B.
    Diabetes Metab; 2015 Apr 15; 41(2):116-25. PubMed ID: 25465273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.